Drugs / Biorepair PERIBIOMA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06148662 | Dec 2023 → Jan 2024 | — | I.M. Sechenov First Moscow State Medical University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Biorepair PERIBIOMA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06148662 ↗ |
| Modality | Other / unclassified | “oral foams containing zink hydroxiapatite and probiotics (Lactobacillus, Bifidobacterium)” NCT06148662 ↗ |